Diagnosing reactive arthritis: Role of clinical setting in the value of serologic and microbiologic assays

Arthritis and Rheumatism

Volumn 46, Issue 2, 2002, Pages 319-327

  Sieper, Joachim ^a   Rudwaleit, Martin ^a   Braun, Jürgen ^a   Van Der Heijde, Désirée ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HASSELT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; DIFFERENTIAL DIAGNOSIS; HUMAN; INFECTION; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REACTIVE ARTHRITIS; REVIEW; SALMONELLA; SERODIAGNOSIS; SPONDYLOARTHROPATHY; YERSINIA;

ANTIBODIES, BACTERIAL; ARTHRITIS, REACTIVE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIOLOGICAL TECHNIQUES; SEROLOGIC TESTS;

EID: 0036169019     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.504     Document Type: Review

References (47)

1. Aetiological agents and immune mechanisms in enterogenic reactive arthritis
2. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy
3. Reactive arthritis: Incidence, triggering agents and clinical presentation
4. Undifferentiated arthritis in an early synovitis out-patient clinic
5. Association of HLA alleles and clinical features in patients with synovitis of recent onset
6. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis
7. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: A three-month, multicenter, double-blind, randomized, placebo-controlled study
8. Reiter's syndrome: Evaluation of preliminary criteria for definite disease
9. Reiter's syndrome and reactive arthritis
10. Reiter's syndrome
11. An overview of clinical spectrum and heterogeneity of spondyloarthropathies
12. Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis
13. A proposal for the classification of patients for clinical and experimental studies on reactive arthritis
14. Problems and advances in the diagnosis of reactive arthritis
15. Third international workshop on reactive arthritis: Report and abstracts
16. Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome
17. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis
18. Chlamydia pneumoniae as a triggering infection in reactive arthritis
19. Report on the fourth international workshop of reactive arthritis
20. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis
21. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic
22. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies
23. Comparison of synovial tissue and synovial fluid as the source of nucleic acids for detection of Chlamydia trachomatis by polymerase chain reaction
24. Lack of correlation between the detection of Chlamydia trachomatis DNA in synovial fluid from patients with a range of rheumatic diseases and the presence of an antichlamydial immune response
25. The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis
26. Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis
27. Testing for Chlamydia trachomatis in urine
28. Chlamydia trachomatis infections in female military recruits
29. Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects
30. Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction
31. Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction
32. Evaluation of commercially available tests for Chlamydia nucleic acid detection in synovial fluid of patients
33. High frequency of Yersinia antibodies in healthy populations in Finland and Germany
34. Summary of notifiable diseases, United States
35. Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis
36. Salmonella-specific antibodies in reactive arthritis
37. Salmonella antibodies in healthy populations in Finland and the UK: How many Salmonella-triggered reactive arthritides are there?
38. Serological diagnosis of salmonella infections by enzyme immunoassay
39. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica 0:3 infection with or without reactive arthritis
40. Reiter's disease and HL-A 27
41. A worldwide overview: The epidemiology of HLA-B27 and associated spondyloarthritides
42. Reactive arthritis following an outbreak of Salmonella infection in Finland
43. Chlamydial serology: Comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens
44. On the difficulties of establishing a consensus of and diagnostic investigations for reactive arthritis: Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis
45. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A department of veterans affairs cooperative study
46. Treatment of reactive arthritis with antibiotics